Revenue Growth QoQ: glpg.com (GLPG)

Corporate emblem and logo of Galapagos NV (GLPG)

Liquidity reserves provide Galapagos NV (GLPG) with stability during its strategic pivot toward cellular oncology. The quarter-over-quarter revenue growth dynamics provided by the GURU.Markets system confirm this, and 1206.60 shows the current value of the metric. The business relies on partner payments and royalties to overcome strict FDA and EMA oversight alongside high R&D costs.

GLPG (Galapagos Genomics) Quarterly Revenue Growth history from 07/04/2022 to 05/08/2026

Summary analytical data breakdowns for Galapagos (GLPG)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
- cash position and cash flow details:
Comprehensive company analysis:GLPG - Galapagos N.V.
Manufactured products of glpg.com

This indicator measures the percentage change in revenue between the current and previous quarters, allowing investors to assess the short-term scaling speed of the business and its reaction to market triggers. By analyzing the quarterly sales dynamics, one can determine how effectively the biolab automation and robotic molecule screening of Galapagos NV (GLPG) convert technological superiority into actual financial growth.

Main competitors

HLN - Revenue Growth QoQ|Quarterly Revenue Growth Rate kenvue.com|Verona Pharma (VRNA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Amneal Pharmaceuticals Inc AMRX|Quarterly Revenue Growth PRGO|Sales Change QoQ ALVO|Quarterly Revenue Growth LQDA (Liquidia Technologies)|Quarterly Revenue Increase ANIP|MNKD - Revenue Growth QoQ|Amphastar - Sales Change QoQ|PCRX: Quarterly Revenue Growth|ars-pharma.com - Quarterly Revenue Increase|TBPH (Theravance Biopharma Inc) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Aquestive Pharma AQST|Quarterly Revenue Growth SCPH|Sales Change QoQ TECX|Revenue Growth QoQ tonixpharma.com TNXP|SXTC (SXT China) - Revenue Dynamics QoQ|Eupraxia Pharmaceuticals - Quarterly Revenue Growth|Quarterly Sales Growth Rate BioHarvest Sciences Inc. BHST|EXOZ: Quarterly Revenue Growth|Oramed (ORMP) - Quarterly Revenue Growth|ENTX (Entera Bio) - Quarterly Revenue Growth|ipatherapeutics.com (HYFT) - Quarterly Sales Growth Rate|Quarterly Revenue Growth ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Quarterly Revenue Increase|Revenue Growth QoQ Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Quarterly Revenue Growth Rate|TELO: Quarterly Sales Growth|Quarterly Sales Growth Rate Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Revenue Growth QoQ|RLYB - Quarterly Sales Growth Rate|Revenue Growth QoQ Lexaria Bioscience|Pulmatrix Corp - Revenue Dynamics QoQ|Revenue Growth QoQ ftzy.com.cn (PTHL)|Aptorum Group - Sales Growth QoQ|Quarterly Revenue Growth LYRA (Lyra Therapeutics Inc.)|Quarterly Sales Growth Rate Impact BioMedical (IBO)|TNF Pharmaceuticals - Quarterly Revenue Growth|Quarterly Revenue Growth Rate cbdMD Inc.|PainReform Ltd. (PRFX) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Altamira Therapeutics (CYTO)|Revenue Growth QoQ Lipella Pharmaceuticals, Inc.|OPTN: Quarterly Revenue Increase|Revenue Growth QoQ Pieris (PIRS)|Quarterly Revenue Growth Procaps Group Corp (PROC)|Quarterly Revenue Growth PTPI (petrospharma.com)|Quarterly Revenue Increase QLI|ACELYRIN - Quarterly Revenue Growth|Quarterly Revenue Increase TFFP (TFF Pharmaceuticals Inc.)